Form 4 for MOH MOLINA HEALTHCARE, INC.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001179929-24-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-05 | 2024-03-01 | MOH | WOYS JAMES | COO | F - Tax | $387.21 | -5,938 | 59.0K | -9% | -$2.30M |
| M | 2024-03-05 | 2024-03-01 | MOH | WOYS JAMES | COO | A - Grant | $387.21 | +16.1K | 64.9K | +33% | +$6.24M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | F | D | 4,515 | $387.21 | 60,387 | D | — | — | (F3) Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. (F2) Represents the closing price of the Issuer's common stock on March 1, 2024. |
| 2 | Common | Common Stock | 2024-03-01 | A | A | 4,649 | $387.21 | 63,613 | D | — | — | (F5) Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. (F2) Represents the closing price of the Issuer's common stock on March 1, 2024. (F6) The shares shall vest as follows: The 4,649 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 3,093 shares shall vest on March 1, 2025; and 1,704 shares shall vest on March 1, 2026. The remaining shares are vested. |
| 3 | Common | Common Stock | 2024-03-01 | F | D | 1,423 | $387.21 | 58,964 | D | — | — | (F4) The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,594 shares on March 1, 2024. (F2) Represents the closing price of the Issuer's common stock on March 1, 2024. |
| 4 | Common | Common Stock | 2024-03-01 | A | A | 11,473 | $387.21 | 64,902 | D | — | — | (F1) Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023. (F2) Represents the closing price of the Issuer's common stock on March 1, 2024. |